Trial intelligence / Profile preview

Therapeutic effect of inhaled budesonide in transient tachypnea of the newborn

TCTR20200513005Phase 2Completed

Sponsor
mohamed shawky elfarargy
Start
Jun 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of budesonide in transient tachypnea of the newborn (TTN), sponsored by mohamed shawky elfarargy. Started Jun 2016; status: completed.

02

Drugs

budesonide
03

Conditions

transient tachypnea of the newborn (TTN)

Beyond the preview

Go deeper on TCTR20200513005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200513005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call